ArticleTherapeutic advances in respiratory diseasePublished
Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study
Regional connection
Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University Hospital, with Temple Health, Temple University linked by the institution reference. Affiliation source
Publication record
- Type
- Article
- Venue
- Therapeutic advances in respiratory disease
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Hypertension, Pulmonary; Pulmonary Fibrosis; Vasodilator Agents; Treatment Outcome; Drug Therapy, Combination; Lung Transplantation; Retrospective Studies; Recovery of Function; Exercise Tolerance; Time Factors; Aged
- PubMed ID
- 40083194
- PubMed Central ID
- PMC11907552
- Open access
- Yes, open
- Added to directory
- Source checked